The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies

Abstract

BackgroundAlzheimer's disease (AD) is the most common cause of dementia characterized by progressive cognitive impairment in the elderly people. The most dramatic abnormalities are those of the cholinergic system. Acetylcholinesterase (AChE) plays a key role in the regulation of the cholinergic system, and hence, inhibition of AChE has emerged as one of the most promising strategies for the treatment of AD.MethodsIn this study, we suggest a workflow for the identification and prioritization of potential compounds targeted against AChE. In order to elucidate the essential structural features for AChE, three-dimensional pharmacophore models were constructed using Discovery Studio 2.5.5 (DS 2.5.5) program based on a set of known AChE inhibitors.ResultsThe best five-features pharmacophore model, which includes one hydrogen bond donor and four hydrophobic features, was generated from a training set of 62 compounds that yielded a correlation coefficient of R = 0.851 and a high prediction of fit values for a set of 26 test molecules with a correlation of R2 = 0.830. Our pharmacophore model also has a high Güner-Henry score and enrichment factor. Virtual screening performed on the NCI database obtained new inhibitors which have the potential to inhibit AChE and to protect neurons from Aβ toxicity. The hit compounds were subsequently subjected to molecular docking and evaluated by consensus scoring function, which resulted in 9 compounds with high pharmacophore fit values and predicted biological activity scores. These compounds showed interactions with important residues at the active site.ConclusionsThe information gained from this study may assist in the discovery of potential AChE inhibitors that are highly selective for its dual binding sites.

Multi-level structure-based pharmacophore modelling of caspase-3-non-peptide complexes: Extracting essential pharmacophore features and its application to virtual screening

“…Opposed to GH score, the enrichment factor (E value) creates a baseline by measuring the number of active compounds obtained from a database search [45]. A GH score in the range of 0.7 to 0.8 represents very good model and a value of 1 indicates the ideal model [46] (rarely found by randomization experiment). The higher the E value, the better is the model in retrieving the actives from a library of molecules [45].…”

Antidementic Activity of Brassica oleracea L. var. Italica (Brassicaceae) Flower on Memory Deficit in Young Male Rats

“…One way ANOVA test was employed. First, a decrease in acetylcholine (ACh), a cholinergic neurotransmitter essential for the process of normal learning , memory and attention as well as a decrease in level of natural antioxidants in the brain by activating microglia, a source of reactive oxygen species (ROS), has been reported [29]. The formation of ROS and other free radicals during metabolism is an important and normal process that is ideally compensated by an elaborate endogenous antioxidant system.…”

Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer’s disease

“…Roy et al used three-dimensional quantitative struc-tureactivity relationship (3D-QSAR) analysis to study and design novel AChE inhibitors [11]. Lu et al used 3D-pharmacophore modeling, virtual screening, and molecular docking to study and design potential highly selective AChE inhibitors [12]. Vitorović-Todorović et al studied 38 4-aryl-4-oxo-2-(N-aryl/ cycloalkyl) butanamides via molecular docking and MD simulations, which afforded useful information for the design and synthesis of AChE and BChE inhibitors [13].…”